Hospital Products

SRI has durable and deep experience in hospital-related market research, conducting both qualitative and quantitative studies with diverse hospital audiences, including hospital administrators, pharmacists, emergency physicians, infectious disease specialists, hospitalists, ICU physicians and nurses, surgeons across multiple specialties, anesthesiologists, nurses, budget decision-makers, and post-operative care teams.

Our expertise covers a broad range of hospital products and indications, such as last-line-of-defense antibiotics, ICU antifungals, anesthesia and reversal agents, surgical implants, wound care products, ophthalmic surgery, and infectious diseases, including community-acquired pneumonia (CAP), acute bacterial sinusitis (ABS), skin and skin structure infections (SSSI), urinary tract infections (UTI), pelvic inflammatory disease (PID), intra-abdominal infections (IAI), acute exacerbations of chronic bronchitis (AECB), invasive fungal infections (IFI), and Helicobacter pylori infections.

SRI undertakes extensive research methodologies, including global multi-indication market opportunity studies, procedural modeling, ATU studies, demand estimation, segmentation, message effectiveness, conjoint/choice modeling, physician and patient tracking, and big data analytics. SRI’s work spans multiple countries with continuous collaboration with client teams to provide actionable strategic insights on treatment decisions, usage drivers, and competitive positioning in the hospital product space.